Awards & Advancement

Telik appoints new board of director members

Friday, August 15, 2014 12:19 PM

Telik, a clinical stage oncology drug development company based in California, which recently merged with MabVax Therapeutics in July, has appointed six new members of the board of directors to help guide the company and its management in developing an expanded product development pipeline post-merger.

More... »

WIRB Copernicus Group

Peter Hirth joins Trovagene's scientific advisory board

Friday, August 15, 2014 10:34 AM

Trovagene, a California-based developer of cell-free molecular diagnostics, has hired K. Peter Hirth, Ph.D., who joins the company's scientific advisory board. A pioneer in the field of personalized medicine, Hirth led the organizations that developed both Sutent and Zelboraf; two successful targeted cancer therapeutics.

More... »


Susan Dallabrida named to PharmaVOICE 100

Friday, August 15, 2014 09:25 AM

PHT has announced Susan Dallabrida, Ph.D., vice president of clinical science and consulting, is among this year’s PharmaVOICE 100 most inspiring professionals in the life sciences industries. Dallabrida is the 6th PHT executive to earn a place on the list. PHT is a provider of technologies used to collect patient-driven eData for clinical research.

More... »

Theravance appoints Michael W. Aguiar as president, CEO

Friday, August 8, 2014 12:29 PM

Theravance has appointed Michael W. Aguiar as president and CEO effective August 15, and as a member of the board of directors effective immediately. Aguiar plans to continue to as Theravance's senior vice president and chief financial officer until his replacement is identified and appointed. 

More... »

HeartWare International appoints Katrin Leadley chief medical officer

Monday, August 4, 2014 03:48 PM

HeartWare International, an innovator of less invasive, miniaturized circulatory support technologies for advanced heart failure, has appointed Katrin Leadley, M.D., as chief medical officer of HeartWare, effective September 1. Leadley brings to HeartWare extensive strategic leadership, with more than 20 years of clinical and industry experience at life sciences firms, including QuintilesBoston Scientific and JenaValve Technology in Munich, where she spent the last three years as chief medical officer leading the company's clinical, regulatory, scientific and medical activities.

More... »

ibidi awarded with seal of quality

Monday, August 4, 2014 03:44 PM

The German Stifterverband, an association that promotes science and education in Germany, has awarded ibidi with their seal of quality for the company's ongoing and focused commitment to research and development.

More... »

INC Research appoints Jan Schreur senior vice president, human resources

Thursday, July 31, 2014 01:22 PM

INC Research, a global phase I to IV CRO, has appointed Jan Schreur as the company's senior vice president, human resources. Schreur brings nearly 30 years of progressive human resources experience to the role, including senior leadership positions at global biopharmaceutical organizations.

More... »

Rho named a Best Place to Work by Triangle Business Journal

Thursday, July 31, 2014 11:36 AM

Rho, a CRO focused on bringing new products to market through a full range of product development services, has been named by Triangle Business Journal a winner of Best Places to Work. The award is part of the publication's annual Best Places to Work Awards program and recognizes Rho’s achievements in creating a positive work environment that attracts and retains employees through a combination of benefits, working conditions and company culture.

More... »

Amy Schulman joins Polaris Partners

Thursday, July 31, 2014 11:24 AM

Polaris Partners has hired biopharmaceutical executive Amy Schulman as a venture partner, based out of Boston, Mass. Schulman, who most recently was general counsel, executive vice president and business unit lead of Pfizer consumer healthcare, will apply decades of experience to the Polaris healthcare portfolio. She also will assume the role of CEO of Arsia Therapeutics, an early stage Polaris-backed company co-founded by Dr. Robert Langer and Polaris partner Alan Crane. 

More... »

David Hall joins Rho as principal investigator of bioinformatics

Wednesday, July 23, 2014 08:00 AM

Rho, a privately held CRO focused on bringing new products to market through a full range of product development services, has announced that David Hall has joined its team as a principal investigator (PI) specializing in bioinformatics at its Research Triangle Park headquarters in North Carolina. David brings more than 12 years of experience in bioinformatics as a principal investigator, general manager, project manager, bioinformatics lead, programmer/analyst, data modeler and software engineer. 

More... »

Subscribe to The CenterWatch Monthly
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

August 18

Ebola outbreak highlights need to improve biosafety, infrastructure to handle future health emergencies

More African American professional women open to participating in medical research

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs